tm logo
Trademark Search
BEQUBOND

View On IC.GC.CA

BEQUBOND
REGISTERED

on 12 Jan 2024

Last Applicant/ Owned by

PRINCIPIA BIOPHARMA INC.

55 Corporate DriveBridgewater NJ 08807

US

Serial Number

2109924 filed on 05th Apr 2021

Registration Number

TMA1218093 registered on 12th Jan 2024

Registration expiry Date

05th Apr 2031

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

BEQUBOND

Trademark usage description

pharmaceutical preparations for the prevention and treatment of immune-mediated namely immune thrombocytopenia, warm auto-immune hemolytic anemia, igg Read More

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of immune-mediated namely immune thrombocytopenia, warm auto-immune hemolytic anemia, IgG4-related diseases, sickle cell disease, autoimmune, inflammatory namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, respiratory, and rare autoimmune diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors

Classification kind code

11

Mark Details

Serial Number

2109924

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 31st Aug 2022		Search Recorded
Submitted for opposition 20
on 31st Aug 2022		Examiner's First Report
Submitted for opposition 135
on 28th Jul 2022		Amendment to Application
Submitted for opposition 256
on 28th Mar 2022		Notification of Possible Opposition Sent
Submitted for opposition 48
on 16th Jul 2021		Agent Changed
Submitted for opposition 257
on 27th May 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 26th May 2021		Created
Submitted for opposition 31
on 26th May 2021		Formalized
Submitted for opposition 30
on 05th Apr 2021		Filed
Submitted for opposition 228
on 05th Apr 2021		International Registration